Limited near term gains for Syngene International stock in pharma space Posted By: Unknown January 04, 2021 Leave a Reply Sharp re-rating has turned the stock into the most expensive in the pharma space from Latest News https://ift.tt/3n4FQ6A https://ift.tt/eA8V8J https://ift.tt/2LUVdkd Tweet Share Share Share Share
0 comments: